In addition to in vitro experiments, knock out of FABP4 in ovarian cancer cells caused decreased tumor burden and number of metastatic nodules in intraperitoneal OC mouse models, convincingly establishing the link between lipid metabolism and the metastatic phenotype. Here, FABP4 is linked to ovarian cancer.